Tandem Diabetes Care Announces First Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance

Go back to Tandem Diabetes Care Announces First Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance

Tandem Diabetes (TNDM) Misses Q1 EPS by 16c

May 4, 2022 4:52 PM EDT

Tandem Diabetes (NASDAQ: TNDM) reported Q1 EPS of ($0.23), $0.16 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $175.9 million versus the consensus estimate of $168.43 million.

GUIDANCE:

Tandem Diabetes sees FY2022 revenue of $850-865 million, versus the consensus of... More